Cencora Inc. (COR)vsQuipt Home Medical Corp (QIPT)
COR
Cencora Inc.
$275.04
-1.90%
HEALTHCARE · Cap: $54.76B
QIPT
Quipt Home Medical Corp
$3.65
0.00%
HEALTHCARE · Cap: $162.30M
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 123942% more annual revenue ($328.68B vs $264.97M). COR leads profitability with a 0.8% profit margin vs -0.0%. COR earns a higher WallStSmart Score of 64/100 (C+).
COR
Buy64
out of 100
Grade: C+
QIPT
Hold40
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-56.3%
Fair Value
$180.05
Current Price
$275.04
$94.99 premium
Margin of Safety
+8.7%
Fair Value
$3.90
Current Price
$3.65
$0.25 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 75 in profit
Earnings expanding 128.3% YoY
Safe zone — low bankruptcy risk
Large-cap with strong market position
Growing faster than its price suggests
Generating 1.2B in free cash flow
Reasonable price relative to book value
Areas to Watch
Trading at 15.8x book value
3.8% revenue growth
0.8% margin — thin
Operating margin of 1.7%
0.3% revenue growth
Smaller company, higher risk/reward
Operating margin of 0.0%
ROE of -0.1% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : COR
The strongest argument for COR centers on Return on Equity, EPS Growth, Altman Z-Score. PEG of 0.60 suggests the stock is reasonably priced for its growth.
Bull Case : QIPT
The strongest argument for QIPT centers on Price/Book.
Bear Case : COR
The primary concerns for COR are Price/Book, Revenue Growth, Profit Margin. Debt-to-equity of 3.65 is elevated, increasing financial risk. Thin 0.8% margins leave little buffer for downturns.
Bear Case : QIPT
The primary concerns for QIPT are Revenue Growth, Market Cap, Operating Margin.
Key Dynamics to Monitor
COR profiles as a value stock while QIPT is a turnaround play — different risk/reward profiles.
COR carries more volatility with a beta of 0.59 — expect wider price swings.
COR is growing revenue faster at 3.8% — sustainability is the question.
COR generates stronger free cash flow (1.2B), providing more financial flexibility.
Bottom Line
COR scores higher overall (64/100 vs 40/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
Quipt Home Medical Corp
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Quipt Home Medical Corp. The company is headquartered in Wilder, Kentucky.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?